THERAVANCE BIOPHARMA INC (TBPH)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Rick E Winningham Chief Executive Officer | 2025 | $1,047,431 | $0 | $0 | $0 | $419,182 | $5,406 | $1,472,019 |
| 2024 | $1,047,431 | $9,802 | $2,443,500 | $0 | $490,198 | $5,000 | $3,995,931 | |
| 2023 | $1,047,431 | $0 | $3,015,100 | $0 | $251,000 | $5,000 | $4,318,531 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Aine Miller Senior Vice President, Development and Head of Ireland Office | 2025 | $506,225 | $0 | $701,250 | $0 | $169,962 | $71,135 | $1,448,573 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Rhonda F. Farnum Chief Business Officer and Senior Vice President, Commercial & Medical Affairs | 2025 | $506,303 | $0 | $701,250 | $0 | $169,263 | $7,376 | $1,384,192 |